Request for Covid-19 Impact Assessment of this Report

Medical Devices

Vietnam Medical Nutrition Market by Product (Infant Nutrition, Parenteral Nutrition, and Enteral Nutrition), Application (Diabetes, Cancer, Gastrointestinal Diseases, Chronic Kidney Disease, Chronic Liver Disease, Intensive Care, Chronic Obstructive Pulmonary Disease, and Others), Distribution Channel (Hospital Pharmacies, Drug Store & Retail Pharmacies, and Online Pharmacies), and End User (Private Hospitals, Public Hospitals, and Homecare): Opportunity Analysis and Industry Forecast, 2020–2027

  • ALL4209118
  • 102 Pages
  • December 2020
  • Medical Devices
Download Sample    Get Discount   
 
The Vietnam medical nutrition market generated $270.16 million in 2019, and is projected to reach $373.05 million by 2027, growing at a CAGR of 5.1% from 2020 to 2027.

Medical nutrition is also referred as clinical nutrition. It means the nutrition required for the management of patients, including not only outpatients at clinics, but also inpatients in hospitals. It includes primarily the scientific fields of nutrition and dietetics. Furthermore, medical nutrition therapy is a specialized, dietician-developed regimen used to treat chronic illness or other medical condition.

The Vietnam medical nutrition market is expected to register substantial growth in the near future, owing to rise in incidence of chronic diseases and surge in geriatric population across Vietnam. However, lack of awareness of nutrition problems among Vietnamese is projected to hamper the market growth during the forecast period. Conversely, rise in medical tourism in Vietnam is expected to offer remunerative opportunities for market players.

The Vietnam medical nutrition market is segmented on the basis of product, application, distribution channel, and end user. By product, the market is categorized into infant nutrition, parenteral nutrition, and enteral nutrition. The parenteral nutrition is further segmented into dextrose based products, fat based products, and additives based products. The enteral nutrition is further segmented into standardized, semi elemental, and specialized. By application, the market is categorized into diabetes, cancer, gastrointestinal diseases, chronic kidney disease, chronic liver disease, intensive care, chronic obstructive pulmonary disease, and others. By distribution channel, the market is classified into hospital pharmacies, drug store & retail pharmacies, and online pharmacies. By end user, the market is segmented into private hospitals, public hospitals, and homecare.

KEY BENEFITS FOR STAKEHOLDERS

 This report provides a detailed quantitative analysis of the current market trends and future estimations from 2020 to 2027, which assists to identify the prevailing market opportunities.

 An in-depth analysis of country is anticipated to provide a detailed understanding of the current trends to enable stakeholders to formulate country-specific plans.

 A comprehensive analysis of the factors that drive and restrain the growth of the Vietnam medical nutrition market is provided.

KEY MARKET SEGMENTS

• By Product

o Infant Nutrition

o Parenteral Nutrition

 Dextrose-based Products

 Fat-based Products

 Additives-based Products

o Enteral Nutrition

 Standardized

 Semi Elemental

 Specialized

• By Application

o Diabetes

o Cancer

o Gastrointestinal Diseases

o Chronic Kidney Disease

o Chronic Liver Disease

o Intensive Care

o Chronic Obstructive Pulmonary Disease

o Others

• By Distribution Channel

o Hospital Pharmacies

o Drug Store & Retail Pharmacies

o Online Pharmacies

• By End User

o Private Hospitals

o Public Hospitals

o Homecare

KEY MARKET PLAYERS

• Abbott Laboratories

• Baxter International Inc.

• B. Braun Melsungen AG.

• Fresenius SE & Co. KGaA.

The other players in the value chain include (profiles not included in the report):

• Danone Nutricia

• Mead Johnson Nutrition Co.

• Nestle S.A.

• Bayer AG

• Pfizer Inc.

• Sanofi S.A.

• GlaxoSmithKline Plc

• Perrigo Company Plc.

CHAPTER 1:INTRODUCTION

1.1.Report description

1.2.Key benefits for stakeholders

1.3.Key market segments

1.4.Research methodology

1.4.1.Secondary research

1.4.2.Primary research

1.4.3.Analyst tools & models

CHAPTER 2:EXECUTIVE SUMMARY

2.1.CXO perspective

CHAPTER 3:MARKET OVERVIEW

3.1.Market definition and scope

3.2.Key findings

3.2.1.Top investment pockets

3.3.Top player positioning

3.4.Porter’s five forces analysis

3.5.Market dynamics

3.5.1.Drivers

3.5.1.1.Rise in incidence of chronic diseases

3.5.1.2.Surge in geriatric population across Vietnam

3.5.2.Restraint

3.5.2.1.Lack of awareness of nutrition problems among Vietnamese

3.5.3.Opportunity

3.5.3.1.Rise in medical tourism in Vietnam

3.6.List of key brands, by product type

3.7.List of key players, by product type

3.8.Average selling price, by product type

3.9.Vietnam key cities data

3.10.Impact analysis of COVID-19 on market

3.10.1.Overview

3.10.2.Impact on the market

CHAPTER 4:VIETNAM MEDICAL NUTRITION MARKET, BY PRODUCT

4.1.Overview

4.1.1.Market size and forecast

4.2.Infant Nutrition

4.2.1.Key market trends, growth factors, and opportunities

4.2.2.Market size and forecast

4.3.Parenteral Nutrition

4.3.1.Key market trends, growth factors, and opportunities

4.3.2.Market size and forecast, by type

4.3.2.1.Dextrose based Products

4.3.2.1.1.Market size and forecast

4.3.2.2.Fat based Products

4.3.2.2.1.Market size and forecast

4.3.2.3.Additives based Products

4.3.2.3.1.Market size and forecast

4.3.3.Market size and forecast

4.4.Enteral Nutrition

4.4.1.Key market trends, growth factors, and opportunities

4.4.2.Market size and forecast, by type

4.4.2.1.Standardized

4.4.2.1.1.Market size and forecast

4.4.2.2.Semi Elemental

4.4.2.2.1.Market size and forecast

4.4.2.3.Specialized

4.4.2.3.1.Market size and forecast

4.4.3.Market size and forecast

CHAPTER 5:VIETNAM MEDICAL NUTRITION MARKET, BY APPLICATION

5.1.Overview

5.1.1.Market size and forecast

5.2.Diabetes

5.2.1.Market size and forecast

5.3.Cancer

5.3.1.Market size and forecast

5.4.Gastrointestinal Diseases

5.4.1.Market size and forecast

5.5.Chronic Kidney Disease

5.5.1.Market size and forecast

5.6.Chronic Liver Disease

5.6.1.Market size and forecast

5.7.Intensive Care

5.7.1.Market size and forecast

5.8.Chronic Obstructive Pulmonary Disease

5.8.1.Market size and forecast

5.9.Others

5.9.1.Market size and forecast

CHAPTER 6:VIETNAM MEDICAL NUTRITION MARKET, BY DISTRIBUTION CHANNEL

6.1.Overview

6.1.1.Market size and forecast

6.2.Hospital Pharmacies

6.2.1.Market size and forecast

6.3.Drug Store & Retail Pharmacies

6.3.1.Market size and forecast

6.4.Online Pharmacies

6.4.1.Market size and forecast

CHAPTER 7:VIETNAM MEDICAL NUTRITION MARKET, BY END USER

7.1.Overview

7.1.1.Market size and forecast

7.2.Private Hospitals

7.2.1.Market size and forecast

7.3.Public Hospitals

7.3.1.Market size and forecast

7.4.Homecare

7.4.1.Market size and forecast

CHAPTER 8:COMPANY PROFILES

8.1.ABBOTT LABORATORIES

8.1.1.Product portfolio

8.1.2.Business performance

8.1.3.Key strategic moves and developments

8.2.B. BRAUN MELSUNGEN AG

8.2.1.Product Portfolio

8.2.2.Business performance

8.3.BAXTER INTERNATIONAL INC.

8.3.1.Product Portfolio

8.3.2.Business performance

8.4.FRESENIUS SE & CO. KGAA

8.4.1.Product portfolio

8.4.2.Business performance

LIST OF TABLES

TABLE 01.LIST OF KEY BRANDS, BY PRODUCT TYPE

TABLE 02.LIST OF KEY PLAYERS, BY PRODUCT TYPE

TABLE 03.AVERAGE SELLING PRICE, BY PRODUCT TYPE

TABLE 04.VIETNAM KEY CITIES DATA

TABLE 05.VIETNAM MEDICAL NUTRITION MARKET, BY PRODUCT, 2019–2027 ($MILLION)

TABLE 06.VIETNAM MEDICAL NUTRITION MARKET FOR PARENTERAL NUTRITION, BY TYPE, 2019–2027 ($MILLION)

TABLE 07.VIETNAM MEDICAL NUTRITION MARKET FOR ENTERAL NUTRITION, BY TYPE, 2019–2027 ($MILLION)

TABLE 08.VIETNAM MEDICAL NUTRITION MARKET, BY APPLICATION 2019-2027($MILLION)

TABLE 09.VIETNAM MEDICAL NUTRITION MARKET, BY DISTRIBUTION CHANNEL, 2019–2027 ($MILLION)

TABLE 10.VIETNAM MEDICAL NUTRITION MARKET, BY END USER, 2019–2027 ($MILLION)

TABLE 11.ABBOTT: PRODUCT PORTFOLIO

TABLE 12.B. BRAUN: PRODUCT PORTFOLIO

TABLE 13.FRESENIUS: PRODUCT PORTFOLIO

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Contact Us

+ 1-888-961-4454

Drop Us an email at

help@bigmarketresearch.com

Similar Reports

Medical Implants Market By Type (Orthopedic Implants, cardiac implants, Stents, Spinal Implants, Neurostimulators, dental implants, Breast Implants, facial Implants) and By Materials (Metallic, Ceramic, Polymers, Natural) - Global Opportunity Analysis and Industry Forecast, 2014 - 2022

Medical implants are permanent devices such as pacemakers or temporary devices such as fracture plates which are removed once their function is completed. These implants are made up of bone, tissue, skin, ceramics, metals, plastics, and other natural materials...

  • Publish Date: August 21, 2016
  • $5370
Ostomy Drainage Bags Market by Type (Colostomy Bags, Ileostomy Bags, Urostomy Bags, Continent Urostomy Bags, and Continent Ileostomy Bags) - Global Opportunity Analysis and Industry Forecast, 2014-2022

Ostomy is a surgery wherein an artificial opening, known as stoma, is created from the colon in the human body to eliminate body wastes such as urine, mucus, and stools, which are collected in artificial bags called ostomy drainage bags. These plastic/rub...

  • Publish Date: December 1, 2016
  • $5370